ChartMill · Sep 28, 2026
The trading volume of these stocks is deviating from the norm in today's session.
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.
XX
NYSE · XXII
22nd Century Group, Inc.
Consumer Defensive · Tobacco
$0.65
Down-$0.02 (-3.60%)
Updated Oct 16, 2026, 1:57 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.89M
- P/E ratio
- -0.6
- Dividend yield
- 0.00%
- 52-week range
- $0.46 – $27.00
- Volume
- 16.7K
- Avg. volume
- 1.63M
Price performance · XXII
XXII price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 14, 2026
XXII closed at $0.65 after 20 trading sessions, down 63.24% for the selected period.
- Last close
- $0.65
- Period change
- -63.24%
- Period low
- $0.65
- Period high
- $2.34
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 14, 2026 | $0.657 | $0.6599 | $0.6341 | $0.6506 | 16.7K |
| Oct 13, 2026 | $0.70 | $0.7027 | $0.6507 | $0.6666 | 79.21K |
| Oct 12, 2026 | $0.82 | $0.82 | $0.6868 | $0.7244 | 104.82K |
| Oct 9, 2026 | $0.837 | $0.879 | $0.801 | $0.8116 | 61.76K |
| Oct 8, 2026 | $0.88 | $0.9061 | $0.83 | $0.8707 | 45.8K |
| Oct 7, 2026 | $0.9147 | $0.9147 | $0.8784 | $0.8915 | 44.85K |
| Oct 6, 2026 | $0.9478 | $0.9478 | $0.863 | $0.9199 | 49.94K |
| Oct 5, 2026 | $0.92 | $0.94 | $0.871 | $0.9119 | 64.61K |
| Oct 2, 2026 | $0.8785 | $0.94 | $0.8501 | $0.914 | 120.74K |
| Oct 1, 2026 | $0.84 | $0.8675 | $0.815 | $0.848 | 54.39K |
| Sep 30, 2026 | $0.8209 | $0.88 | $0.7901 | $0.8401 | 113.13K |
| Sep 29, 2026 | $1.03 | $1.07 | $0.7852 | $0.8018 | 254.43K |
| Sep 28, 2026 | $1.34 | $1.34 | $0.9114 | $0.9547 | 487.42K |
| Sep 25, 2026 | $1.51 | $1.51 | $1.20 | $1.33 | 193.82K |
| Sep 24, 2026 | $1.86 | $1.86 | $1.1501 | $1.51 | 855.26K |
| Sep 23, 2026 | $1.81 | $2.60 | $1.69 | $2.34 | 2.7M |
| Sep 22, 2026 | $1.77 | $1.8855 | $1.77 | $1.81 | 27.08K |
| Sep 21, 2026 | $1.81 | $1.85 | $1.757 | $1.77 | 20.79K |
| Sep 18, 2026 | $1.75 | $1.89 | $1.74 | $1.79 | 31.97K |
| Sep 17, 2026 | $1.74 | $1.7898 | $1.6802 | $1.77 | 13.77K |
Latest XXII news
The latest Smart Investors Daily articles mentioning XXII.
Stock researchCompany · Overview
Company
Market Activity
Research & News
XXII research
Overview
Company profile and research snapshot.
Company profile
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $82.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 23, 2023 | Roth MKM | Buy | — |
| Aug 17, 2023 | Alliance Global Partners | Neutral | — |
| Aug 15, 2023 | Dawson James | Buy | — |
| Aug 15, 2023 | TD Cowen | Market Perform | — |
| Nov 9, 2022 | Alliance Global Partners | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 28, 2026
22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction Initiative
Independent French health agency ANSES recommends a maximum nicotine limit for all combustible tobacco product; the Company's supply now includes non-GMO reduced-nicotine tobacco, addressing a key feasibility question for France and the EU MOCKSVILLE, N.C., Sept. 28, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), the only low nicotine tobacco company in the world, today highlighted the findings of a scientific assessment published by ANSES, France's National Agency for Food, E
Benzinga · Sep 28, 2026
22nd Century Group Announces Study From France's ANSES Identifies Its Technology Supportive In Nicotine Reduction In Combustible Tobacco Products
22nd Century Group, Inc. (NASDAQ:XXII), the only low nicotine tobacco company in the world, today highlighted the findings of a scientific assessment published by ANSES, France's National Agency for Food,
Yahoo · Sep 24, 2026
22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final Rule
22nd Century Group Calls on HHS Secretary Kennedy, Acting FDA Commissioner Diamantas and CTP Director Koplow to Enact and Implement the Reduced Nicotine Content Standard Administration’s Reported Move to Accelerate Vape and Nicotine Pouch Authorizations Addresses Only Part of the Continuum of Risk MOCKSVILLE, N.C., Sept. 24, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today calle
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
